TSBX — TURNSTONE BIOLOGICS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
TSBX (TURNSTONE BIOLOGICS CORP) is tracked on HoldingsHub across five years of quarterly 13F filings. 63 funds have reported positions historically, with the sum of their latest reported stakes valued at $6.64M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of TURNSTONE BIOLOGICS CORP (TSBX) include EVENTIDE ASSET MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Zimmer Partners, LP, ranked by reported 13F value among the 63 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2025 | 21 | 7.52M | $2.70M | -15.6% |
| Q1 2025 | 22 | 9.52M | $3.90M | -3.0% |
| Q4 2024 | 27 | 10.26M | $5.09M | -0.7% |
| Q3 2024 | 23 | 10.61M | $5.91M | -2.2% |
| Q2 2024 | 43 | 11.85M | $31.04M | -2.8% |
| Q1 2024 | 38 | 11.78M | $30.87M | -0.6% |
| Q4 2023 | 34 | 11.79M | $29.98M | -1.5% |
| Q3 2023 | 35 | 11.88M | $46.77M | — |
Over the 8 quarters shown, institutional share counts decreased 37% in aggregate (Q3 2023 → Q2 2025).
Top Institutional Holders (Q2 2025) — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $1.11M | 0.03% | Hold | |
| 1.13M | $407.10K | 0.00% | Hold | |
| 1.10M | $396.12K | 0.30% | Hold | |
| 816.92K | $293.27K | 0.00% | Reduce | |
| 549.98K | $197.44K | 0.52% | Hold | |
| 208.89K | $74.99K | 0.00% | New | |
| 130.08K | $46.70K | 0.00% | Reduce | |
| 106.06K | $38.07K | 0.01% | New | |
| 83.93K | $30.13K | 0.00% | Reduce | |
| 79.31K | $28.47K | 0.00% | Add | |
| 55.86K | $20.00K | 0.00% | Add | |
| 47.10K | $16.91K | 0.00% | Add | |
| 45.16K | $16.21K | 0.00% | New | |
| 37.79K | $13.56K | 0.00% | Add | |
| 18.41K | $6.61K | 0.00% | Hold | |
| 4.74K | $1.70K | 0.00% | Hold | |
| 1.07K | $383 | 0.00% | Reduce | |
| 158 | $57 | 0.00% | Reduce | |
| 150 | $54 | 0.00% | Reduce | |
| 121 | $43 | 0.00% | Hold | |
| 71 | $25 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2025 — 22 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $1.27M | 0.03% | Hold | |
| 1.13M | $464.94K | 0.00% | Reduce | |
| 1.10M | $452.39K | 0.37% | New | |
| 932.35K | $382.26K | 0.03% | Hold | |
| 891.53K | $365.53K | 0.00% | Hold | |
| 878.93K | $360.36K | 0.00% | Reduce | |
| 549.98K | $225.49K | 0.63% | Hold | |
| 515.09K | $211.19K | 0.00% | Reduce | |
| 136.78K | $56.09K | 0.00% | Reduce | |
| 42.40K | $17.38K | 0.00% | Reduce | |
| 40.20K | $16.48K | 0.00% | Add | |
| 38.86K | $15.93K | 0.00% | Reduce | |
| 38.86K | $15.93K | 0.00% | Reduce | |
| 35.74K | $14.65K | 0.00% | Add | |
| 25.30K | $10.38K | 0.00% | Reduce | |
| 20.00K | $8.20K | 0.00% | New | |
| 18.41K | $7.55K | 0.00% | Hold | |
| 12.08K | $4.00K | 0.00% | New | |
| 4.76K | $1.95K | 0.00% | Reduce | |
| 196 | $81 | 0.00% | Reduce | |
| 121 | $50 | 0.00% | Reduce | |
| 71 | $29 | 0.00% | Hold |
Q4 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $1.54M | 0.03% | Hold | |
| 1.18M | $586.10K | 0.00% | Add | |
| 934.36K | $464.29K | 0.00% | Hold | |
| 932.35K | $463.28K | 0.03% | Hold | |
| 891.53K | $442.20K | 0.00% | Reduce | |
| 689.21K | $342.47K | 0.00% | Hold | |
| 579.00K | $286.60K | 0.00% | Hold | |
| 549.98K | $273.29K | 0.56% | Hold | |
| 517.65K | $257.22K | 0.17% | Hold | |
| 192.66K | $95.36K | 0.00% | Hold | |
| 138.66K | $68.65K | 0.00% | Add | |
| 114.06K | $56.67K | 0.00% | Add | |
| 73.74K | $36.50K | 0.00% | Reduce | |
| 73.74K | $36.50K | 0.00% | Reduce | |
| 67.32K | $33.33K | 0.00% | New | |
| 61.41K | $30.40K | 0.00% | New | |
| 43.19K | $21.46K | 0.00% | Add | |
| 23.90K | $11.88K | 0.00% | New | |
| 20.52K | $10.20K | 0.00% | New | |
| 18.41K | $9.14K | 0.00% | Hold | |
| 15.24K | $7.57K | 0.00% | New | |
| 14.81K | $7.00K | 0.00% | New | |
| 11.76K | $5.82K | 0.00% | New | |
| 4.81K | $2.39K | 0.00% | Reduce | |
| 4.70K | $2.34K | 0.00% | Reduce |
Q3 2024 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $1.73M | 0.03% | Hold | |
| 1.17M | $653.47K | 0.00% | Add | |
| 932.35K | $519.41K | 0.03% | Hold | |
| 932.23K | $519.34K | 0.00% | Reduce | |
| 911.74K | $507.84K | 0.00% | Hold | |
| 689.21K | $383.96K | 0.00% | Add | |
| 579.00K | $322.50K | 0.00% | Hold | |
| 549.98K | $306.39K | 0.66% | Hold | |
| 517.65K | $288.38K | 0.17% | Hold | |
| 454.03K | $253.00K | 0.00% | Reduce | |
| 192.66K | $107.33K | 0.00% | Hold | |
| 132.82K | $74.00K | 0.00% | Add | |
| 110.04K | $61.31K | 0.00% | Reduce | |
| 103.03K | $57.40K | 0.00% | Reduce | |
| 103.03K | $57.40K | 0.00% | Reduce | |
| 49.88K | $27.79K | 0.00% | Reduce | |
| 42.93K | $23.91K | 0.00% | New | |
| 18.41K | $10.25K | 0.00% | Reduce | |
| 10.64K | $5.93K | 0.00% | Add | |
| 6.00K | $3.34K | 0.00% | Reduce | |
| 4.98K | $2.77K | 0.00% | Reduce | |
| 800 | $446 | 0.00% | Reduce | |
| 158 | $88 | 0.00% | Reduce |
Q2 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $8.12M | 0.17% | Hold | |
| 1.14M | $2.97M | 0.00% | Reduce | |
| 1.12M | $2.93M | 0.01% | Reduce | |
| 932.35K | $2.44M | 0.12% | Add | |
| 910.78K | $2.39M | 0.00% | Add | |
| 684.63K | $1.79M | 0.00% | Hold | |
| 579.00K | $1.52M | 0.00% | Add | |
| 549.98K | $1.44M | 3.62% | Hold | |
| 517.65K | $1.36M | 0.55% | Hold | |
| 464.82K | $1.22M | 0.01% | Add | |
| 458.32K | $1.20M | 0.02% | Hold | |
| 216.14K | $566.28K | 0.01% | Add | |
| 192.66K | $504.76K | 0.00% | Hold | |
| 125.86K | $329.75K | 0.00% | New | |
| 125.86K | $329.75K | 0.00% | New | |
| 115.98K | $303.86K | 0.00% | Reduce | |
| 94.23K | $246.89K | 0.00% | Reduce | |
| 73.29K | $192.01K | 0.00% | New | |
| 71.95K | $188.56K | 0.00% | Reduce | |
| 53.68K | $140.65K | 0.00% | Add | |
| 51.29K | $134.39K | 0.00% | Add | |
| 36.61K | $95.92K | 0.00% | New | |
| 35.77K | $93.72K | 0.01% | New | |
| 25.23K | $66.09K | 0.00% | New | |
| 24.90K | $65.24K | 0.00% | Reduce |
Q1 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.10M | $8.12M | 0.15% | Hold | |
| 1.57M | $4.13M | 0.00% | Reduce | |
| 1.18M | $3.10M | 0.01% | Add | |
| 920.98K | $2.41M | 0.12% | Add | |
| 899.37K | $2.36M | 0.00% | Reduce | |
| 684.84K | $1.79M | 0.00% | Reduce | |
| 549.98K | $1.44M | 2.15% | Hold | |
| 517.65K | $1.36M | 0.53% | Hold | |
| 458.32K | $1.20M | 0.02% | Reduce | |
| 369.78K | $969.00K | 0.01% | Add | |
| 369.68K | $968.55K | 0.00% | Add | |
| 238.08K | $623.83K | 0.00% | Add | |
| 192.66K | $504.76K | 0.00% | Hold | |
| 179.03K | $469.05K | 0.01% | Add | |
| 121.38K | $318.02K | 0.00% | Add | |
| 99.47K | $260.62K | 0.00% | Add | |
| 59.90K | $156.94K | 0.00% | Hold | |
| 38.49K | $100.85K | 0.00% | Add | |
| 34.44K | $90.24K | 0.00% | Add | |
| 34.44K | $90.24K | 0.00% | Add | |
| 32.75K | $85.80K | 0.00% | New | |
| 23.59K | $61.82K | 0.00% | Add | |
| 23.37K | $61.23K | 0.00% | New | |
| 19.06K | $49.93K | 0.00% | Add | |
| 18.84K | $49.37K | 0.00% | Hold |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 3.10M | 3.10M | 3.10M | 3.10M | 3.10M | 3.10M | 3.10M | 3.10M |
| Fidelity Management & Research (FMR) | 1.13M | 1.13M | 1.18M | 1.17M | 1.14M | 1.57M | 2.55M | 2.83M |
| BML Capital Management, LLC | 1.10M | 1.10M | — | — | — | — | — | — |
| Point72 Asset Management | 816.92K | 878.93K | 934.36K | 932.23K | 1.12M | 1.18M | 833.33K | 833.33K |
| 72 Investment Holdings, LLC | 549.98K | 549.98K | 549.98K | 549.98K | 549.98K | 549.98K | 549.98K | 549.98K |
| Citadel Advisors | 208.89K | — | 689.21K | 689.21K | 684.63K | 684.84K | 688.47K | 687.45K |
| Geode Capital Management | 130.08K | 136.78K | 138.66K | 132.82K | 71.95K | 238.08K | 121.94K | 110.50K |
| DELTEC ASSET MANAGEMENT LLC | 106.06K | — | — | — | — | — | — | — |
| Vanguard Group | 83.93K | 515.09K | 579.00K | 579.00K | 579.00K | 369.68K | 296.61K | 108.61K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 79.31K | 25.30K | 67.32K | — | 51.29K | 23.37K | — | — |
| HRT FINANCIAL LP | 55.86K | 12.08K | — | — | — | — | — | — |
| Renaissance Technologies | 47.10K | 40.20K | 23.90K | — | — | — | — | — |
| GTS SECURITIES LLC | 45.16K | — | — | — | — | — | — | — |
| XTX Topco Ltd | 37.79K | 35.74K | 11.76K | — | — | — | — | — |
| Northern Trust Corp | 18.41K | 18.41K | 18.41K | 18.41K | 94.23K | 99.47K | 65.07K | 57.78K |
| Tower Research Capital LLC (TRC) | 4.74K | 4.76K | 4.81K | 4.98K | 10.50K | 3.41K | 3.79K | 479 |
| BlackRock Inc | 1.07K | 42.40K | 43.19K | 42.93K | — | — | — | — |
| JPMorgan Chase & Co | 158 | 196 | 199 | 158 | 6.84K | 6.17K | 4.22K | 4.22K |
| Bank of America Corp | 150 | 891.53K | 891.53K | 911.74K | 910.78K | 899.37K | 914.06K | 8.52K |
| BNP PARIBAS FINANCIAL MARKETS | 121 | 121 | 15.24K | — | — | — | — | — |
FAQ
Which funds hold TSBX?
63 funds have reported positions in TSBX across five years of 13F filings; the sum of their latest reported stakes is $6.64M.
Who are the top institutional holders of TSBX?
The largest 13F holders are EVENTIDE ASSET MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Zimmer Partners, LP, Fidelity Management & Research (FMR), BML Capital Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of TURNSTONE BIOLOGICS CORP?
The major shareholders of TURNSTONE BIOLOGICS CORP (TSBX) by reported 13F value are EVENTIDE ASSET MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Zimmer Partners, LP, Fidelity Management & Research (FMR), BML Capital Management, LLC, among 63 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.